Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. The Company’s business segments include life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment provides application-focused solutions that include instruments and software. The Company's diagnostics and genomics business segment includes the genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership and biomolecular analysis businesses. The Company's Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
52 Week high
52 Week low
Seeking Alpha • 8 days ago • AAgilent Not As Agile As Hoped As Life Sciences Demand Proves To Be Less Than Invincible
Seeking Alpha • 9 days ago • AAgilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Business Wire • 14 days ago • AAgilent Announces Cash Dividend of 22.5 Cents Per Share
Zacks Investment Research • 15 days ago • AAgilent (A) Boosts Genomic Profiling With New Collaboration
Business Wire • 23 days ago • AAgilent Technologies and Exact Sciences Agree to Terms of Sale for Resolution Bioscience
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.